نتائج البحث - Jonathan Golas

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)

    Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1) حسب Matthew Sung, Xingzhi Tan, Bingwen Lu, Jonathan Golas, Christine Hosselet, Fang Wang, Laurie Tylaska, Lindsay King, Dahui Zhou, Russell G. Dushin, Jeremy S. Myers, Edward Rosfjord, Judy Lucas, Hans‐Peter Gerber, Frank Loganzo

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models

    SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models حسب Jennifer M. Golas, Judy Lucas, Carlo Etienne, Jonathan Golas, Carolyn Discafani, Latha Sridharan, Erwin R. Boghaert, Kim Arndt, Fei Ye, Diane H. Boschelli, Fangbiao Li, Craig Titsch, Christine Huselton, Inder Chaudhary, Frank Boschelli

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors

    Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors حسب Changhua Ji, Marc D. Roy, Jonathan Golas, Allison Vitsky, Sripad Ram, Steven W. Kumpf, Matthew T. Martin, Frank Barletta, William A. Meier, Andrea T. Hooper, Puja Sapra, Nasir Khan, Martin B. Finkelstein, Magali Guffroy, Bernard S. Buetow

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

    Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase حسب Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord, Michelle Baxter, M. Brawner Floyd, Jonathan Golas, William Hallett, Bernard D. Johnson, Ramaswamy Nilakantan, Elsebe Overbeek, Marvin F. Reich, Ru Shen, Xiaoqing Shi, Hwei‐Ru Tsou, Yu‐Fen Wang, Allan Wissner

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma

    Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma حسب Pedro Molina-Sánchez, Marina Ruiz de Galarreta, Melissa A. Yao, Katherine E. Lindblad, Erin Bresnahan, Elizabeth Bitterman, Tiphaine Martin, Troy Rubenstein, Kai Nie, Jonathan Golas, Shambhunath Choudhary, Marina Bárcena‐Varela, Abdülkadir Elmas, Verónica Miguela, Ying Ding, Zhengyan Kan, Lauren Tal Grinspan, Kuan‐lin Huang, Ramon Parsons, David J. Shields, Robert A. Rollins, Amaia Lujambio

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

    A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers حسب Divya Mathur, Adam R. Root, Bozena Bugaj‐Gaweda, Stephanie Bisulco, Xingzhi Tan, Wei Fang, Jessica Kearney, Justin Lucas, Magali Guffroy, Jonathan Golas, Cynthia M. Rohde, Chad Stevens, Cris Kamperschroer, Kerry Kelleher, Rosemary F. Lawrence-Henderson, Erik Upeslacis, Johnny Yao, Jatin Narula, Edward R. LaVallie, Diane R. Fernandez, Bernard S. Buetow, Edward Rosfjord, Laird Bloom, Lindsay E. King, Lioudmila Tchistiakova, Anhco Nguyen, Puja Sapra

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: